The Ethics of Genetic Commerce By
2007 | 233 Pages | ISBN: 1405166983 | PDF | 2 MB
Our rapidly expanding genetic knowledge today points toward a near future in which the elements of humanity closest to our moral core may themselves be produced, manipulated, commodified, and exchanged. Explores the moral and ethical concerns derived from an increasing knowledge of genetics and the variety of its commercial applications A major contribution to the emerging understanding of the role that ethics will play in genetic commerce Written by experts from the academic and corporate sector, with diverse backgrounds in business, social science, and philosophy Addresses a range of relevant issues, including genetic screening, the use of individual's genetic information, the rise of genetically modified foods, patenting, pharmaceutical mergers and monopolization, and the implications of genetic testing on non-human mammalsContent: Chapter 1 Is a Genetics Screening Program for Job Applicants Ethical? An Analysis of the Conditions Necessary for Requiring Genetic Screenings in the Hiring Process (pages 3-24): Thomas HarterChapter 2 The Business Ethics of Genetic Screening (pages 25-41): Duane WindsorChapter 3 Genetic Commerce: The Challenges for Human Resource Management (pages 42-54): Karen S. Markel and Lizabeth A. BarclayChapter 4 Geneticize Me! The Case for Direct?to?Consumer Genetic Testing (pages 55-69): Ronald MunsonChapter 5 Proscription, Prescription, or Market Process? Comments on Genetic Screening (pages 70-83): Eugene HeathChapter 6 Transgenic Organisms, the European Union, and the World Trade Organization (pages 87-108): Dennis CooleyChapter 7 Commercialization of the Agrarian Ideal and Arguments Against the New "Green Revolution": Feeding the World with "Frankenfoods"? (pages 109-126): Johann A. KlaassenChapter 8 Corporate Decisions About Labeling Genetically Modified Foods (pages 127-138): Chris MacDonald and Melissa WhellamsChapter 9 Moral Imagination, Stakeholder Engagement, and Genetically Modified Organisms (pages 139-142): Denis G. ArnoldChapter 10 Who Owns My Ideas About Your Body? (pages 145-176): Asher MeirChapter 11 Pharmaceutical Mergers and Genetic Technology: A Problematic Combination (pages 177-189): Michael PottsChapter 12 Stakeholder Care Theory: The Case of Genetic Engineering and Non?Human Mammals (pages 190-207): Jamie R. HendryChapter 13 Unresolved Issues and Further Questions: Meir, Potts, and Hendry (pages 208-213): Laura Hartman